Achieve Life Sciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FRANKLIN RESOURCES INC | 02/12/2025 | 3.85 M | $13.56 M | -0.49% | 12.01% |
| PROPEL BIO MANAGEMENT, LLC | 02/14/2025 | 2.45 M | $8.63 M | 0.00% | 7.65% |
| BLACKROCK, INC. | 02/07/2025 | 2.09 M | $7.34 M | 0.74% | 6.51% |
| SOFINNOVA INVESTMENTS, INC. | 02/14/2025 | 1.31 M | $4.60 M | -13.71% | 4.07% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 755,845 | $2.66 M | 0.90% | 2.36% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 654,000 | $2.30 M | 0.00% | 2.04% |
| STATE STREET CORP | 02/14/2025 | 436,470 | $1.54 M | 1.15% | 1.36% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/14/2025 | 421,000 | $1.48 M | -10.62% | 1.31% |
| NORTHERN TRUST CORP | 02/14/2025 | 416,796 | $1.47 M | 11.71% | 1.30% |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 02/14/2025 | 248,099 | $873,308 | 0.00% | 0.77% |
| SIMPLIFY ASSET MANAGEMENT INC. | 02/11/2025 | 217,845 | $766,814 | 0.00% | 0.68% |
| RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 157,519 | $554,467 | 100.00% | 0.49% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 61,160 | $215,283 | 70.55% | 0.19% |
| DUMAC, INC. | 02/14/2025 | 50,000 | $176,000 | 100.00% | 0.16% |
| CITIGROUP INC | 02/12/2025 | 47,093 | $165,767 | 88.86% | 0.15% |
| PALE FIRE CAPITAL SE | 02/13/2025 | 41,420 | $145,798 | 25.06% | 0.13% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 36,168 | $127,311 | 36.96% | 0.11% |
| SHAY CAPITAL LLC | 02/14/2025 | 25,000 | $88,000 | -94.44% | 0.08% |
| J. GOLDMAN & CO LP | 02/14/2025 | 24,548 | $86,409 | 0.00% | 0.08% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 19,733 | $69,460 | 4.42% | 0.06% |
| MANCHESTER FINANCIAL INC | 01/30/2025 | 19,630 | $69,098 | 0.00% | 0.06% |
| BERKSHIRE ASSET MANAGEMENT LLC/PA | 02/07/2025 | 17,700 | $52,746 | 0.00% | 0.06% |
| SQUAREPOINT OPS LLC | 02/14/2025 | 17,519 | $61,667 | 100.00% | 0.05% |
| COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 17,123 | $60,273 | -7.02% | 0.05% |
| INTECH INVESTMENT MANAGEMENT LLC | 02/11/2025 | 16,343 | $57,527 | 100.00% | 0.05% |
| 02/06/2025 | 14,023 | $49,361 | 100.00% | 0.04% | |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 13,173 | $46,369 | 14,375.82% | 0.04% |
| WINDSOR CAPITAL MANAGEMENT, LLC | 01/28/2025 | 10,817 | $38,076 | 0.00% | 0.03% |
| SIGMA PLANNING CORP | 02/03/2025 | 10,600 | $37,312 | 100.00% | 0.03% |
| MADISON PARK CAPITAL ADVISORS, LLC | 01/17/2025 | 10,000 | $35,200 | 0.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 7,545 | $26,558 | 185.80% | 0.02% |
| 02/11/2025 | 6,924 | $24,372 | 100.00% | 0.02% | |
| LEGAL & GENERAL GROUP PLC | 02/13/2025 | 3,484 | $12,263 | 0.00% | 0.01% |
| STEPHENS CONSULTING, LLC | 01/27/2025 | 3,000 | $10,560 | 0.00% | 0.01% |
| ALLWORTH FINANCIAL LP | 01/30/2025 | 3,000 | $9,210 | 0.00% | 0.01% |
| FMR LLC | 02/13/2025 | 2,575 | $9,064 | 25.18% | 0.01% |
| AMALGAMATED BANK | 02/04/2025 | 1,192 | $4,000 | 0.00% | 0.00% |
| STERLING CAPITAL MANAGEMENT LLC | 02/13/2025 | 482 | $1,697 | 653.13% | 0.00% |
| CORNERSTONE PLANNING GROUP LLC | 01/29/2025 | 100 | $311 | 0.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 02/10/2025 | 26 | $92 | 100.00% | 0.00% |
| VERITION FUND MANAGEMENT LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CAPTION MANAGEMENT, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CAPITAL PERFORMANCE ADVISORS LLP | 01/31/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Achieve Life Sciences, Inc. institutional Ownership - FAQ's
During the previous two years, 46 institutional investors and hedge funds held shares of Achieve Life Sciences, Inc.. The most heavily invested institutionals were:
FRANKLIN RESOURCES INC: 3.85 M
Propel Bio Management, LLC: 2.45 M
BlackRock, Inc.: 2.09 M
Sofinnova Investments, Inc.: 1.31 M
GEODE CAPITAL MANAGEMENT, LLC: 755,845
Nantahala Capital Management, LLC: 654,000
50.95% of Achieve Life Sciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 15.53 M shares in the last 24 months. This purchase volume represents approximately $33.86 M in transactions.